Skip to content

Clinical trials

Recruiting Scleroderma, Systemic trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Status: Recruiting Country / region: China Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20221
20233
20249
202519
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting40

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing GoBroad Hospital5
China Immunotech (Beijing) Biotechnology Co., Ltd.4
Peking University Third Hospital4
The Children's Hospital of Zhejiang University School of Medicine3
Anhui Provincial Hospital2
Chongqing Precision Biotech Co., Ltd2
Nanjing Bioheng Biotech Co., Ltd.2
Boehringer Ingelheim1
Changhai Hospital1
CytoCares Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic40
Lupus Erythematosus, Systemic22
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis18
Myositis14
Autoimmune Diseases10
Sjogren's Syndrome10
Antiphospholipid Syndrome8
Arthritis, Rheumatoid7
Lupus Nephritis4
Dermatomyositis3

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.